Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000190558 | SCV000051588 | benign | Arrhythmogenic right ventricular cardiomyopathy | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000038209 | SCV000061877 | likely benign | not specified | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000858416 | SCV000236190 | benign | not provided | 2018-05-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25637381, 20400443, 20857253, 23299917, 23810883, 24832006, 20829228, 23861362, 25351510, 26743238, 26656175, 26332594, 28341588, 29582136, 30731207, 31402444) |
Ambry Genetics | RCV000244829 | SCV000318609 | likely benign | Cardiovascular phenotype | 2018-10-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000458904 | SCV000557321 | likely benign | Arrhythmogenic right ventricular dysplasia 9 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000458904 | SCV000743445 | likely benign | Arrhythmogenic right ventricular dysplasia 9 | 2017-06-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000458904 | SCV000744692 | likely benign | Arrhythmogenic right ventricular dysplasia 9 | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000776101 | SCV000910922 | likely benign | Cardiomyopathy | 2018-04-10 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000458904 | SCV001138676 | benign | Arrhythmogenic right ventricular dysplasia 9 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000858416 | SCV001148690 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | PKP2: BS2 |
Illumina Laboratory Services, |
RCV000458904 | SCV001272955 | uncertain significance | Arrhythmogenic right ventricular dysplasia 9 | 2019-08-02 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000038209 | SCV001362101 | benign | not specified | 2023-06-12 | criteria provided, single submitter | clinical testing | Variant summary: PKP2 c.2431C>A (p.Arg811Ser) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0009 in 253076 control chromosomes (gnomAD, Fressart_2010, Klauke_2010, Tan_2010), including 1 homozygote in the gnomAD database. The observed variant frequency is approximately 1.4 fold of the estimated maximal expected allele frequency for a pathogenic variant in PKP2 causing Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (0.00065), suggesting that the variant is benign. c.2431C>A has been reported in the literature in individuals affected with ARVD and other cardiological phenotypes (Fressart_2010, Klauke_2010, Tan_2010, Bottillo_2016, Proost_2017, Chua_2018, Sahlin_2019), however without strong evidence for pathogenicity (i.e. lack of co-segregation data), these reports do not provide unequivocal conclusions about association of the variant with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. In addition, co-occurrences with other pathogenic variants have been reported in the literature (MYBPC3 c.3192dup (p.Lys1065fsX12), Bottillo_2016; DSG2 c.137G>A, p.Arg46Gln, Fressart_2010), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24832006, 23299917, 26656175, 29582136, 20400443, 20829228, 23810883, 28341588, 30615648, 20857253). Eleven ClinVar submitters have assessed the variant since 2014: one classified the variant as uncertain significance, seven as likely benign, and three as benign. Based on the evidence outlined above, the variant was classified as benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV000776101 | SCV002043317 | benign | Cardiomyopathy | 2020-03-03 | criteria provided, single submitter | clinical testing | |
Dept of Medical Biology, |
RCV003318347 | SCV004022020 | uncertain significance | Long QT syndrome | 2024-01-08 | criteria provided, single submitter | research | Criteria: BS1, PP3 |
CSER _CC_NCGL, |
RCV000148730 | SCV000190464 | uncertain significance | Familial isolated arrhythmogenic right ventricular dysplasia | 2014-06-01 | no assertion criteria provided | research | |
Diagnostic Laboratory, |
RCV000458904 | SCV000733154 | likely benign | Arrhythmogenic right ventricular dysplasia 9 | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000858416 | SCV001799796 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000858416 | SCV001925606 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000858416 | SCV001953349 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003934921 | SCV004754302 | likely benign | PKP2-related disorder | 2019-05-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |